Finding DNA Modifications in RNA with Protein-Assisted Sequencing

Jim Crocker
11th April, 2025

Finding DNA Modifications in RNA with Protein-Assisted Sequencing

The DRAM system introduces a novel method to detect 5-methylcytosine (m5C) by using a reader protein to guide a deaminase enzyme to the modification, which in turn induces specific, detectable mutations that flag the m5C site's location (a, b).

Image adapted from: Zhou et al. / CC BY (Source)

Key Findings

  • Researchers at Jilin University in China created DRAM, a new tool to accurately map genetic changes called m5C in RNA
  • DRAM works with very small RNA samples and avoids errors common in older methods, making it more reliable
  • This breakthrough helps scientists better understand gene control and could lead to new disease treatments
Understanding the intricate modifications within our genetic material is essential for unraveling the complexities of cellular functions and disease mechanisms. One such modification, 5-Methylcytosine (m5C), occurs in messenger RNA (mRNA) and plays a significant role in regulating gene expression and maintaining cellular health. However, accurately mapping m5C across the entire transcriptome has been challenging due to limitations in existing detection methods. Researchers at Jilin University in Changchun, China, have developed a novel technique called DRAM (deaminase and reader protein assisted RNA methylation analysis) to address this issue[1]. m5C is a chemical modification where a methyl group is added to the fifth carbon of the cytosine base in RNA. This modification influences various biological processes, including mRNA stability, translation efficiency, and the overall regulation of gene expression. Dysregulation of m5C has been linked to several diseases, including cancer and neurological disorders. Therefore, understanding the precise locations and functions of m5C modifications is crucial for developing targeted therapies and diagnostic tools. Traditional methods for detecting m5C, such as bisulfite sequencing, have limitations in terms of accuracy, comprehensiveness, and the amount of RNA required for analysis. Bisulfite sequencing involves treating RNA with bisulfite, which converts unmethylated cytosines to uracil, allowing for the identification of methylated sites. However, this method can be prone to errors and often requires large amounts of RNA, making it less suitable for studies with limited samples. The DRAM system developed by the Jilin University team offers a significant improvement over existing techniques. DRAM utilizes a combination of deaminases and m5C reader proteins to identify m5C sites without the need for antibodies or bisulfite treatment. Specifically, the method involves fusing deaminases, such as APOBEC1 and TadA-8e, with m5C reader proteins like ALYREF and YBX1. These fused proteins target m5C sites and induce deamination events in neighboring cytosines, which can then be detected through sequencing. This innovative approach enhances the accuracy and comprehensiveness of m5C mapping across the transcriptome. One of the key advantages of the DRAM system is its ability to work with ultralow input RNA, requiring as little as 10 nanograms. This makes it particularly useful for studies involving limited or precious samples, such as those derived from specific cell types or clinical biopsies. Additionally, DRAM's results show a high degree of overlap with existing bisulfite sequencing datasets, validating its reliability and effectiveness in identifying m5C loci. The development of DRAM builds upon previous research that has highlighted the importance of RNA modifications in regulating gene expression and cellular functions. For instance, earlier studies have demonstrated that enzymes like APOBEC3A play a critical role in nucleic acid modification and have implications for both antiviral defense and genome editing technologies[2]. The use of APOBEC1 in the DRAM system leverages the deaminase activity of these enzymes to accurately identify methylated sites, showcasing the practical application of fundamental enzymatic functions in advanced genomic techniques. Furthermore, research on tRNA cytosine methylation has shown that specific RNA modifications can significantly impact protein expression and neuronal function, linking molecular changes to complex behaviors[3]. By providing a more precise method for mapping m5C in mRNA, DRAM allows scientists to explore how these modifications influence various biological processes and contribute to disease pathogenesis. This connection underscores the broader significance of accurately detecting RNA modifications in understanding cellular mechanisms and developing therapeutic interventions. In addition to enhancing our ability to map m5C, the DRAM system also offers insights into the regulation of mRNA stability, a critical factor in gene expression control. mRNA stability determines how long a transcript remains available for translation into proteins, thereby influencing the overall protein levels within a cell. Previous reviews have highlighted the role of various RNA modifications, including m5C, in modulating mRNA stability by affecting the secondary and tertiary structures of RNA and the binding of regulatory proteins[4]. By providing a more detailed map of m5C modifications, DRAM enables a deeper investigation into how these chemical changes influence mRNA lifespan and function. The implications of the DRAM system extend beyond basic research, offering potential applications in medical diagnostics and personalized medicine. Accurate mapping of m5C modifications could lead to the identification of biomarkers for various diseases, facilitating early diagnosis and the development of targeted treatments. Moreover, understanding the role of m5C in gene regulation may reveal new therapeutic targets for conditions where RNA modifications are dysregulated. In summary, the DRAM system developed by researchers at Jilin University represents a significant advancement in the field of epitranscriptomics. By providing a more accurate, comprehensive, and efficient method for mapping m5C modifications in mRNA, DRAM enhances our understanding of the complex regulatory mechanisms that govern gene expression and cellular function. This breakthrough not only addresses the limitations of existing detection methods but also opens new avenues for research into the biological roles of RNA modifications and their implications for human health and disease[2][4].

BiotechGeneticsBiochem

References

Main Study

1) Transcriptome-wide identification of 5-methylcytosine by deaminase and reader protein-assisted sequencing

Published 8th April, 2025

https://doi.org/10.7554/eLife.98166

Related Studies

2) The Base-Editing Enzyme APOBEC3A Catalyzes Cytosine Deamination in RNA with Low Proficiency and High Selectivity.

https://doi.org/10.1021/acschembio.1c00919

3) Neuronal Nsun2 deficiency produces tRNA epitranscriptomic alterations and proteomic shifts impacting synaptic signaling and behavior.

https://doi.org/10.1038/s41467-021-24969-x

4) The emerging role of RNA modifications in the regulation of mRNA stability.

https://doi.org/10.1038/s12276-020-0407-z


Related Articles

An unhandled error has occurred. Reload 🗙